We describe two cases of moyamoya disease
associated with headache which had been diagnosed as
migraine with aura meeting the International Headache
Society criteria. Administration of triptan was clinically
effective. Initial computed tomography and magnetic
resonance imaging of the brain showed no abnormalities,
which made the diagnosis of moyamoya disease difficult. We
discuss the pathophysiological mechanism of migraine-like
headache caused by moyamoya disease. Proper
neuroradiological investigation such as MRA may become
mandatory even in patients with typical symptom of MWA,
because triptans have relative contraindication in patients
with moyamaya disease.
Open Access
Peer Reviewed
ISSN: 2378-8933
Neurological Research and Therapy
International open-access publishing for high-quality research, reviews, case studies, and scholarly communication.
Submit Manuscript
Original Research
Article in Press
Triptan Is Effective for the Migraine with Aura-Like Headache Associated With Moyamoya Disease
Koichi Hirata1, Akinori Hozumi1, Akio Iwasaki1, Yuji Watanabe1, Eisei Hoshiyama1 and Fumihiko Sakai2*
Corresponding Author: Koichi Hirata
Received: Aug 28, 2014
Accepted: Oct 20, 2014
Published: Oct 24, 2014
Views: 4
DOI: 10.14437
Abstract
Koichi Hirata (2014), Triptan Is Effective for the Migraine with Aura-Like Headache Associated With Moyamoya
Disease. Neurol Res Ther Open Access 1:102
Copyright:
Copyright: © 2014 NRTOA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, Version 3.0, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Indexed In
Google Scholar
DOAJ
PubMed
Scopus